Pahl; Axel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pahl; Axel.The latest application filed is for "hepatitis c inhibitors and uses thereof".

Company Profile

0.7.9

Pahl; Axel - Lindwedel DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hepatitis C inhibitors and uses thereof Grant 9,567,355 - Maring , et al. February 14, 2	2017-02-14
Hepatitis C Inhibitors And Uses Thereof App 20160355530 - Maring; Clarence J. ; et al.	2016-12-08
Hepatitis C inhibitors and uses thereof Grant 9,453,007 - Maring , et al. September 27, 2	2016-09-27
Hepatitis C Inhibitors And Uses Thereof App 20160002213 - Maring; Clarence J. ; et al.	2016-01-07
Hepatitis C Inhibitors And Uses Thereof App 20140038919 - Maring; Clarence J. ; et al.	2014-02-06
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them Grant 7,452,875 - Hoeltje , et al. November 18, 2	2008-11-18
Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them Grant 7,427,611 - Hoeltje , et al. September 23, 2	2008-09-23
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them Grant 7,410,962 - Hoeltje , et al. August 12, 2	2008-08-12
4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7H-pyrrolo [2,3D] pyrimidine hydrogen mesylate, its polymorphic forms, and methods for making same Grant 7,381,729 - Pahl , et al. June 3, 2	2008-06-03
Amidomethyl-Substituted 1-(Carboxyalkyl) Cyclopentyl-Carbonylamino-Benzazepine-N-Acetic Acid Compounds, Process and Intermediate Products for Their Preparation and Pharmaceutical Compositions Containing Them App 20080085889 - Hoeltje; Dagmar ; et al.	2008-04-10
Amidomethyl-substituted 1-(carboxyalkyl) Cyclopentyl-carbonylamino-benzazepine-n-acetic Acid Compounds, Process And Intermediate Products For Their Preparation And Pharmaceutical Compositions Containing Them App 20070265244 - Hoeltje; Dagmar ; et al.	2007-11-15
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them Grant 7,262,184 - Hoeltje , et al. August 28, 2	2007-08-28
Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them App 20060281732 - Hoeltje; Dagmar ; et al.	2006-12-14
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzaze- pine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them App 20050119247 - Hoeltje, Dagmar ; et al.	2005-06-02
4- (4-trans-hydroxycyclohexyl)amino-2-phenyl-7H-pyrrolo [2,3D] pyrimidine hydrogen mesylate, its polymorphic forms, and methods for making same App 20040248912 - Pahl, Axel ; et al.	2004-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.